Mundipharma Submits New Analgesic Targin (Prolonged Release Oxycodone / Naloxone Combination) For European Approval
Mundipharma announced that Targin, an oral prolonged-release oxycodone / naloxone combination tablet, has been submitted for regulatory approval in Europe. Targin is a combination of a strong opioid receptor agonist, oxycodone, and a locally acting opioid receptor antagonist, naloxone.
More: continued here